Work Absence Following COVID-19 Vaccination in a Cohort of Healthcare Personnel

被引：11

作者：

Breeher, Laura E. ^{[1
,2
]}

Wolf, Michael E. ^{[2
]}

Geyer, Holly ^{[3
,4
]}

Brinker, Todd ^{[5
,6
]}

Tommaso, Christopher ^{[1
]}

Kohlnhofer, Stacy ^{[7
]}

Hainy, Caitlin ^{[1
]}

Swift, Melanie ^{[1
,2
]}

机构：

[1] Mayo Clin, Occupat Hlth Serv, Practice Adm, Rochester, MN USA

[2] Mayo Clin, Div Prevent Occupat & Aerosp Med, Rochester, MN USA

[3] Mayo Clin, Occupat Hlth Serv, Scottsdale, AZ USA

[4] Mayo Clin, Dept Hosp Internal Med, Scottsdale, AZ USA

[5] Mayo Clin, Employee Hlth Serv, Jacksonville, FL 32224 USA

[6] Mayo Clin, Dept Family Med, Jacksonville, FL 32224 USA

[7] Mayo Clin, Recovery & Claims Serv, Rochester, MN USA

来源：

JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE | 2022年 / 64卷 / 01期

关键词：

COVID-19; healthcare; side effects; vaccine; work absence; UNITED-STATES;

D O I：

10.1097/JOM.0000000000002376

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Objective: To identify rates of work absence following receipt of COVID-19 vaccine in a cohort of healthcare personnel (HCP). Methods: Short-term disability (STD) usage by HCP attributed to side effects of the COVID-19 vaccine was calculated for each vaccine manufacturer, job category, age group, and work region. Analysis was performed for the cohort of HCP during the initial vaccination campaign. Results: 4.1% of COVID-19 vaccinations generated a STD claim for lost work due to side effects, with increased STD rates after dose 2 than dose 1 (7.4% and 0.9%, respectively). Rates were higher for younger HCP and allied health staff. Conclusions: While side effects from mRNA vaccine dose 2 resulted in more work absence, statistically significant geographic differences in STD suggest cultural and staffing factors may impact HCP to utilize STD following vaccination.

引用

页码：6 / 9

页数：4

共 15 条

[1] [Anonymous], 2021, The cost of missed work due to COVID-19.
[2] Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Baden, Lindsey R.
El Sahly, Hana M.
Essink, Brandon
Kotloff, Karen
Frey, Sharon
Novak, Rick
Diemert, David
Spector, Stephen A.
Rouphael, Nadine
Creech, C. Buddy
McGettigan, John
Khetan, Shishir
Segall, Nathan
Solis, Joel
Brosz, Adam
Fierro, Carlos
Schwartz, Howard
Neuzil, Kathleen
Corey, Larry
Gilbert, Peter
Janes, Holly
Follmann, Dean
Marovich, Mary
Mascola, John
Polakowski, Laura
Ledgerwood, Julie
Graham, Barney S.
Bennett, Hamilton
Pajon, Rolando
Knightly, Conor
Leav, Brett
Deng, Weiping
Zhou, Honghong
Han, Shu
Ivarsson, Melanie
Miller, Jacqueline
Zaks, Tal
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) : 403 - 416
[3] Bauer L., 2020, HAMILTON PROJECT 10
[4] Healthcare personnel absenteeism, presenteeism, and staffing challenges during epidemics
Challener, Douglas W.
Breeher, Laura E.
Frain, JoEllen
Swift, Melanie D.
Tosh, Pritish K.
O'Horo, John
[J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2021, 42 (04) : 388 - 391
[5] Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines
Chapin-Bardales, Johanna
Gee, Julianne
Myers, Tanya
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (21): : 2201 - 2202
[6] Association of Vaccine Type and Prior SARS-CoV-2 Infection With Symptoms and Antibody Measurements Following Vaccination Among Health Care Workers
Debes, Amanda K.
Xiao, Shaoming
Colantuoni, Elizabeth
Egbert, Emily R.
Caturegli, Patrizio
Gadala, Avinash
Milstone, Aaron M.
[J]. JAMA INTERNAL MEDICINE, 2021, 181 (12) : 1660 - 1662
[7] First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021
Gee, Julianne
Marques, Paige
Su, John
Calvert, Geoffrey M.
Liu, Ruiling
Myers, Tanya
Nair, Narayan
Martin, Stacey
Clark, Thomas
Markowitz, Lauri
Lindsey, Nicole
Zhang, Bicheng
Licata, Charles
Jazwa, Amelia
Sotir, Mark
Shimabukuro, Tom
[J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (08): : 283 - 288
[8] Oliver SE, 2020, MMWR-MORBID MORTAL W, V69, P1922, DOI 10.15585/mmwr.mm6950e2
[9] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, Fernando P.
Thomas, Stephen J.
Kitchin, Nicholas
Absalon, Judith
Gurtman, Alejandra
Lockhart, Stephen
Perez, John L.
Perez Marc, Gonzalo
Moreira, Edson D.
Zerbini, Cristiano
Bailey, Ruth
Swanson, Kena A.
Roychoudhury, Satrajit
Koury, Kenneth
Li, Ping
Kalina, Warren V.
Cooper, David
Frenck, Robert W., Jr.
Hammitt, Laura L.
Tureci, Ozlem
Nell, Haylene
Schaefer, Axel
Unal, Serhat
Tresnan, Dina B.
Mather, Susan
Dormitzer, Philip R.
Sahin, Ugur
Jansen, Kathrin U.
Gruber, William C.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (27) : 2603 - 2615
[10] Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
Sadoff, Jerald
Gray, Glenda
Vandebosch, An
Cardenas, Vicky
Shukarev, Georgi
Grinsztejn, Beatriz
Goepfert, Paul A.
Truyers, Carla
Fennema, Hein
Spiessens, Bart
Offergeld, Kim
Scheper, Gert
Taylor, Kimberly L.
Robb, Merlin L.
Treanor, John
Barouch, Dan H.
Stoddard, Jeffrey
Ryser, Martin F.
Marovich, Mary A.
Neuzil, Kathleen M.
Corey, Lawrence
Cauwenberghs, Nancy
Tanner, Tamzin
Hardt, Karin
Ruiz-Guinazu, Javier
Le Gars, Mathieu
Schuitemaker, Hanneke
Van Hoof, Johan
Struyf, Frank
Douoguih, Macaya
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (23) : 2187 - 2201

← 1 2 →